Discussion about this post

User's avatar
mark's avatar

Congratulations on the book, I just preordered!

Expand full comment
Matthew Zuck's avatar

FYI - incomplete or non-systematic US healthcare is a feature not a bug for the pharmaceutical/health complex... for instance, by having the most cases of Covid, we have the most data which increase the likelihood that US companies will play a key role in “solutions” and then will be able to monetize that throughout the world. Incomplete coverage ensures a degree of cases to study while also resulting in an economic model of selling services at high margins or “high prices” - so the us health ecosystem “works” or is adaptive because elements of it both maximize the “surface” for discovery and the “volume” of profits... it’s non-obvious, but this is why their is such resilient resistance to making what would seem like obvious changes to create a comprehensive or systematic or functional health care system... the system would arguably function less well in terms of innovation, profit, and the care options for the wealthy... one persons feature is another’s bug and vice versa and the ultimate definition is just a matter of who has the power...

Expand full comment
4 more comments...

No posts